Featured Asia Pacific Experience
Cowen Group in Strategic Partnership with CEFC China
Willkie represented Cowen Group, Inc., a diversified financial services firm, in its strategic partnership with China Energy Company Limited (CEFC China), whereby CEFC China agreed to acquire approximately 19.9% of Cowen’s outstanding common shares for an aggregate purchase price of approximately $100 million. In addition to the equity investment, CEFC China, the largest private company in Shanghai, also agreed to provide Cowen with $175 million in debt financing.
Fortress Investment Group to Be Acquired by SoftBank Group
Willkie represented Morgan Stanley as financial advisor to Fortress Investment Group in its $3.3 billion acquisition by Japan-based SoftBank Group.
Genworth Financial in $2.7 Billion Pending Acquisition by China Oceanwide
Willkie represented Genworth Financial in its $2.7 billion pending acquisition by China Oceanwide; the transaction includes an additional $1.1 billion capital contribution.
AssetMark to Be Acquired by Huatai Securities
Willkie represented AssetMark, Inc. in its purchase by Huatai Securities from Aquiline Capital Partners and Genstar Capital.
WuXi PharmaTech Enters Into $3.3 Billion LBO
Willkie represented the Special Committee of the Board of Directors of WuXi PharmaTech Inc. in its $3.3 billion management-led leveraged buyout, one of the largest going private transactions of a Chinese-based, U.S. listed company.
Dai-ichi Life in $5.7 Billion Acquisition of Protective Life
Willkie represented Tokyo-based Dai-ichi Life Insurance Company, Limited in its $5.7 billion acquisition of Protective Life Corporation. Dai-ichi Life, the second largest private life insurance company in Japan, is one of the top 20 global life insurers, operating throughout Japan, Australia, Vietnam, Indonesia, India and Thailand.
Cornerstone Investor in Largest-Ever IPO in Thailand
Willkie advised a cornerstone investor in BTS Group Holdings PCL's $2.13 billion initial public offering, the largest-ever IPO in Thailand.
Sepracor in $2.6 Billion Acquisition by Dainippon Sumitomo Pharma
Japanese pharmaceutical manufacturer Dainippon Sumitomo Pharma Co., Ltd. (DSP) acquired Willkie client Sepracor Inc., a specialty drug maker, for approximately $2.6 billion.
iParadigms in $752 Million Sale
GIC, Singapore's sovereign wealth fund, and Insight Venture partners agreed to acquire Willkie client iParadigms, a California-based anti-plagiarism software company, from majority owner Warburg Pincus.